Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas

1998 
(57) Abstract: The present invention is the use of a series of aryl ureas in treating raf mediated diseases, to pharmaceutical compositions for use in such therapy.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []